NBSE
NeuBase Therapeutics, Inc. Common Stock
NBSE
NBSE
Delisted
NBSE was delisted on the 10th of May, 2024.
47 hedge funds and large institutions have $36.6M invested in NeuBase Therapeutics, Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 12 increasing their positions, 17 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
91% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 11
Holders
47
Holding in Top 10
–
Calls
$147K
Puts
$119K
Top Buyers
| 1 | +$284K | |
| 2 | +$271K | |
| 3 | +$247K | |
| 4 |
JAMONY
Jacob Asset Management of New York
Hermosa Beach,
California
|
+$224K |
| 5 |
TAM
Tocqueville Asset Management
New York
|
+$163K |
Top Sellers
| 1 | -$695K | |
| 2 | -$527K | |
| 3 | -$389K | |
| 4 |
Two Sigma Investments
New York
|
-$358K |
| 5 |
First Trust Advisors
Wheaton,
Illinois
|
-$350K |